The third quarter financial results of Guardant Health (NASDAQ: GH) will be unveiled on Wednesday 6th November 2024. This eagerly awaited announcement is scheduled to occur after market close.
Financial analysts on Wall Street are anticipating that the company will announce an estimated $0.74 loss per share for the quarter. Furthermore, the firm is projected to disclose a total revenue of $170.62 million for this period.
The projections from Wall Street analysts indicate that the company is expected to generate a total revenue of $695.22 million for the full year. Moreover, they anticipate the earnings per share to reach loss of $3.14 during the fiscal year.
The company's earnings report from the corresponding quarter of the previous year demonstrated a per-share loss of $0.67. Additionally, the company achieved a total revenue of $143.03 million during that specific period.
The business has scheduled a conference call on 6th November 2024 at 04:30 PM eastern time to discuss Q3 financial results.
During Friday's trading, Guardant Health (GH) shares reached a low of $22.15 and a high of $23.19, along with a total volume of 1.99 million shares. The stock ended the regular trading session at $23.00, marking an upturn of 5.12 percent.
